IART R&D to Revenue
Integra Lifesciences Holdings Corp · R&D to Revenue
IART R&D to Revenue
Latest reported6.05%period ending
IART FY R&D/Revenue (50.98% → 6.05%)
Latest values, visible window
High-resolution chart · PNG
IART r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.0524% | |
| 7.1639% | |
| 6.7588% | |
| 6.4965% | |
| 6.0327% | |
| 5.6406% | |
| 5.2435% | |
| 5.3001% | |
| 5.3403% | |
| 5.862% | |
| 5.7656% | |
| 5.5581% | |
| 6.229% | |
| 6.1396% | |
| 6.5956% | |
| 6.5723% | |
| 6.488% | |
| 9.2415% | |
| 5.5695% | |
| 6.1369% | |
| 4.3032% | |
| 6.1442% | |
| 6.9041% | |
| 7.3731% | |
| 8.5529% | |
| 11.5777% | |
| 20.4706% | |
| 48% | |
| 43.5374% | |
| 48.0916% | |
| 50.9804% |